Tanaka, H., Maezawa, M., Tanaka, M., Umetsu, R., Hirofuji, S., Miyasaka, K., . . . Nakamura, M. Analysis of adverse events with ruxolitinib using real-world datasets and drug-interaction networks. SAGE Publishing.
Chicago Style (17th ed.) CitationTanaka, Hideyuki, et al. Analysis of Adverse Events with Ruxolitinib Using Real-world Datasets and Drug-interaction Networks. SAGE Publishing.
MLA (9th ed.) CitationTanaka, Hideyuki, et al. Analysis of Adverse Events with Ruxolitinib Using Real-world Datasets and Drug-interaction Networks. SAGE Publishing.
Warning: These citations may not always be 100% accurate.